Witnessed cardiac arrests tied to better EMS resuscitation outcomes
A retrospective registry analysis found higher odds of return of circulation when arrests were witnessed or began with PEA, but it did not test treatment effects.
301–320
A retrospective registry analysis found higher odds of return of circulation when arrests were witnessed or began with PEA, but it did not test treatment effects.
The guidance cites lower reported kidney and heart-failure risks, but says evidence remains limited in the very elderly, frail and severely malnourished.
A peer-reviewed laboratory study found Compound 2 had lower DNA reactivity than three other platinum compounds, but its precise binding site remains unknown.
A study of 35 captive-bred birds found social integration was associated with tighter movement patterns, but not a significant survival difference.
A laboratory study reports high yields and five-cycle reuse, while broader testing and scale-up remain to be done.
A peer-reviewed assessment found sufficient efficacy for grapevine and sports-turf uses, while modeled exposure for grape hand-harvesting exceeded the AOEL.
A randomized crossover study found that 10 and 20 microgram doses changed self-reported vision, while the main behavioral measure showed no drug-condition effect.
A six-person masked-arrow study paired repeated Bayesian testing with a direct awareness check, but its key conclusion depends on the relative sensitivity of the two tasks.
High-frequency oscillation rates separated the predefined group with active epileptic spasms from other EEG categories, but the measure still needs larger validation before clinical use.
A Bradford Hill review finds no consistent mental-health signal, but says mixed evidence leaves treatment-related risks unresolved.
A review of 201 patients found fewer severe adverse-event episodes with intrathecal treatment, but the comparison was small, indirect and dominated by melanoma cases.
A 100-day experiment found lower progesterone, reduced antioxidant activity and changes in developing ovarian follicles, but it did not test fertility in people.
A narrative review reports activity in laboratory and animal studies, while warning that inconsistent tests and limited safety data block clinical conclusions.
A laboratory study links the result to charge shifts and a changing surface, while leaving full-scale electrolyzer tests open.
Higher TRIM59 tracked with advanced disease and shorter survival, while cell and mouse experiments linked it to growth, invasion and PTRF protein turnover. Treatment response was not tested.
A Preprint study reports weaker MYH9-G3BP1 binding and fewer contacts between stress granules and P-bodies in cells exposed to repeated stress.
A peer-reviewed review of 84 articles says targeted drugs may help resistant disease, but much of the evidence comes from mixed lupus populations.
The preclinical work tied the protein to mitochondrial energy production, but it did not test HS1BP3-engineered cells in patients.
A Dutch cohort study found the association three months after diagnosis, but the observational results do not show that diet prevents cancer from returning or advancing.
In mice, Pabpc4 knockout was linked to smaller tumors and stronger CD8+ T-cell activity; human data showed associations, not clinical benefit.